| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/21/2011 | US20110091893 Biosensors for detecting macromolecules and other analytes |
| 04/21/2011 | US20110091892 Methods for the Diagnosis and Treatment of Lung Cancer |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091875 Three-component gene expression reporting system for mammalian cells and applications of the same |
| 04/21/2011 | US20110091868 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 04/21/2011 | US20110091523 Cochleate compositions directed against expression of proteins |
| 04/21/2011 | US20110091505 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091504 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091502 Human parvovirus: humink parvovirus |
| 04/21/2011 | US20110091501 Recombinant Rhinovirus Vectors |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091496 Methods and compositions for the delivery of vaccines to disrupted epithelium |
| 04/21/2011 | US20110091495 Hcv e2 construct compositions and methods |
| 04/21/2011 | US20110091494 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 04/21/2011 | US20110091493 Vaccine compositions and uses thereof |
| 04/21/2011 | US20110091491 Hiv-1 gp41 neutralization domain and use thereof |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091477 Modulators of hepatocyte growth factor activator |
| 04/21/2011 | US20110091476 Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091464 Novel peptides and protein and uses thereof |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091460 Receptor-targeting reagents |
| 04/21/2011 | US20110091441 Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof |
| 04/21/2011 | US20110091437 Fusion proteins |
| 04/21/2011 | US20110091417 Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders |
| 04/21/2011 | US20110091416 Immunoglobulin fusion proteins |
| 04/21/2011 | US20110091413 Therapeutic use of interleukin-2 mutants |
| 04/21/2011 | US20110091412 Mutant interleukin-2 (il-2) polypeptides |
| 04/21/2011 | US20110091407 Polymer derived from linear polyethylenimine for gene transfer |
| 04/21/2011 | US20110091386 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110088361 Novel tomato plants |
| 04/21/2011 | DE112008003318T5 Pflanzen mit erhöhtem Ertrag und erhöhter Toleranz gegenüber Umweltstress (IY-B) Plants with increased yield and increased tolerance to environmental stress (IY-B) |
| 04/21/2011 | CA2811817A1 Epigenetic dna enrichment |
| 04/21/2011 | CA2780741A1 Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
| 04/21/2011 | CA2777920A1 Aptamer capable of binding to viral hemorrhagic septicemia virus |
| 04/21/2011 | CA2777835A1 Supercoiled minicircle dna for gene therapy applications |
| 04/21/2011 | CA2777744A1 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites |
| 04/21/2011 | CA2777717A1 Chimeric fibroblast growth factors with altered receptor specificity |
| 04/21/2011 | CA2777699A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 04/21/2011 | CA2777692A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | CA2777628A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
| 04/21/2011 | CA2777459A1 Microorganisms for the production of 1,4-butanediol, 4-hydroxybutanal, 4-hydroxybutyryl-coa, putrescine and related compounds, and methods related thereto |
| 04/21/2011 | CA2777448A1 Compositions for controlling varroa mites in bees |
| 04/21/2011 | CA2777362A1 Method to control spider mites |
| 04/21/2011 | CA2777249A1 Manipulation of flavonoid biosynthetic pathway |
| 04/21/2011 | CA2777116A1 Process for adenovirus purification from high cell density cultures |
| 04/21/2011 | CA2777030A1 Use of dendrimer nanotechnology for delivery of biomolecules into plant cells |
| 04/21/2011 | CA2776461A1 Method for the purification of adenovirus particles |
| 04/21/2011 | CA2776392A1 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens |
| 04/21/2011 | CA2776001A1 Mycobacterial vaccines |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | CA2775563A1 Drought tolerant plants and related constructs and methods involving genes encoding self-incompatibility protein related polypeptides |
| 04/21/2011 | CA2775402A1 Il-1 binding proteins |
| 04/21/2011 | CA2775277A1 Infectious clones of torque teno virus |
| 04/20/2011 | EP2312316A1 Anti-EPHA2 antibodies as a cancer diagnostic |
| 04/20/2011 | EP2311994A1 Compositions and methods for preparing short RNA molecules and other nucleic acids |
| 04/20/2011 | EP2311992A1 Method for rapid detection and identification of bioagents |
| 04/20/2011 | EP2311980A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311979A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/20/2011 | EP2311978A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/20/2011 | EP2311973A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/20/2011 | EP2311969A1 Method of producing lactic acid by continuous fermentation |
| 04/20/2011 | EP2311967A2 Improved AAV vectors produced in insect cells |
| 04/20/2011 | EP2311966A2 Improved AAV vectors produced in insect cells |
| 04/20/2011 | EP2311965A1 Glutamine-rich maize seed protein and promoter |
| 04/20/2011 | EP2311964A1 Method to increase stress tolerance in plants |
| 04/20/2011 | EP2311963A2 Methods for increasing the resistance of plants to hypoxic conditions |
| 04/20/2011 | EP2311962A1 Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides |
| 04/20/2011 | EP2311961A1 Model-guided random assembly PCR for the synthesis of eukaryotic promoters |
| 04/20/2011 | EP2311960A2 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 04/20/2011 | EP2311959A2 Nucleotide sequences of canola and soybean palmitoyl-ACP thioesterase genes and their use in the regulation of fatty acid content of the oils of soybean and canola plants |
| 04/20/2011 | EP2311958A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/20/2011 | EP2311957A1 Antigens from granulocytic Ehrlichia |
| 04/20/2011 | EP2311956A1 Methods for making APO-2 ligand using divalent metal ions |
| 04/20/2011 | EP2311955A2 Osteoprotegerin binding proteins and their receptors |
| 04/20/2011 | EP2311954A1 Mutations in the Parkin gene, compositions, methods and uses |
| 04/20/2011 | EP2311953A1 Bone/joint disease susceptibility gene and use thereof |
| 04/20/2011 | EP2311952A2 Antibodies to MRT-1 protein or fragments thereof |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311949A2 Antisense compounds targeted to connexins and methods of use thereof |
| 04/20/2011 | EP2311948A1 RNA-interference for ZNFN3A1-gene as a method for inhibiting cancer cell growth |
| 04/20/2011 | EP2311947A1 Protein synthesis via click chemistry |
| 04/20/2011 | EP2311946A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 04/20/2011 | EP2311945A1 Bispecific antibodies substituting for functional proteins |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311940A1 Novel sesquiterpene synthases and methods of their use |
| 04/20/2011 | EP2311939A1 Polypeptide immobilization |
| 04/20/2011 | EP2311895A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 04/20/2011 | EP2311882A1 Reducing the immunogenicity of fusion proteins |
| 04/20/2011 | EP2311881A2 Cripto binding molecules |
| 04/20/2011 | EP2311880A2 Cripto binding molecules |
| 04/20/2011 | EP2311873A1 M-CSF-specific monoclonal antibody and uses thereof |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311870A1 Compositions and methods for the treatment of immune related diseases |